B42.7
Disseminated sporotrichosis
Clinical Classification Guidelines
Inclusion Terms
- Generalized sporotrichosis
Medical Intelligence & Overview
Disseminated sporotrichosis, classified under ICD-10 code B42.7, is a rare and severe form of sporotrichosis, a fungal infection caused by the fungus Sporothrix schenckii. Unlike localized infections that affect specific areas, disseminated sporotrichosis involves multiple organ systems throughout the body, making it a more serious condition that requires prompt medical attention. This form of sporotrichosis is often seen in individuals with weakened immune systems and can pose significant health challenges. Recognizing the signs and understanding its underlying causes can facilitate early diagnosis and appropriate treatment.
Causes & Symptoms
Clinical Causes: Infection with the fungus Sporothrix schenckii, typically acquired through traumatic skin injuries involving contaminated plant material or soil. Spread of the infection from initial cutaneous lesions to other parts of the body via the bloodstream or lymphatic system. Immunosuppression due to conditions like HIV/AIDS, corticosteroid therapy, cancer treatments, or other immune-compromising illnesses, which increase susceptibility to widespread fungal infections. Occupational exposure, especially among agricultural workers, gardeners, or forestry personnel who handle soil or plant material that contains Sporothrix schenckii. In rare cases, disseminated sporotrichosis can occur without obvious trauma, especially in individuals with severely weakened immune defenses.
Key Symptoms: Multiple skin lesions that may vary from nodules and ulcers to abscesses Swelling and redness around affected areas Fever and chills in more severe or systemic cases Lymph node enlargement near infected skin sites Presence of lesions in internal organs such as the lungs, bones, joints, or the central nervous system General symptoms like fatigue, malaise, and weight loss Possible symptoms related to specific organ involvement, for example, cough or chest pain if the lungs are affected
Diagnostic & Treatment
Diagnosis Path: Skin biopsies and tissue samples from lesions for microscopic examination and fungal culture to identify Sporothrix schenckii Blood tests to detect fungal elements or antibodies against the fungus Imaging studies such as X-rays, CT scans, or MRI scans to assess internal organ involvement Histopathological examination to observe characteristic fungal structures within tissue samples Assessment of immune system function to determine any underlying immunosuppression
Treatment Protocols: Oral or intravenous antifungal drugs such as itraconazole, amphotericin B, or terbinafine based on severity and extent of infection In some cases, surgical intervention may be necessary to remove infected tissue or drain abscesses Managing underlying immunosuppression to boost the body's ability to fight the infection Regular monitoring through laboratory tests to assess response to therapy Supportive care to address symptoms and prevent complications
Clinical Advice & FAQs
Billing Guidance
Is B42.7 a billable ICD-10 code?
Yes, B42.7 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B42.7?
Clinical documentation must specify the nature of Disseminated sporotrichosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference